GB0014006D0 - Novel pharmaceutical - Google Patents

Novel pharmaceutical

Info

Publication number
GB0014006D0
GB0014006D0 GBGB0014006.1A GB0014006A GB0014006D0 GB 0014006 D0 GB0014006 D0 GB 0014006D0 GB 0014006 A GB0014006 A GB 0014006A GB 0014006 D0 GB0014006 D0 GB 0014006D0
Authority
GB
United Kingdom
Prior art keywords
novel pharmaceutical
pharmaceutical
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0014006.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0014006.1A priority Critical patent/GB0014006D0/en
Publication of GB0014006D0 publication Critical patent/GB0014006D0/en
Priority to US10/297,651 priority patent/US20030162815A1/en
Priority to AU2001264078A priority patent/AU2001264078A1/en
Priority to DZ013382A priority patent/DZ3382A1/en
Priority to IL15327901A priority patent/IL153279A0/en
Priority to HU0301137A priority patent/HUP0301137A3/en
Priority to EA200300005A priority patent/EA200300005A1/en
Priority to JP2002501893A priority patent/JP2003535862A/en
Priority to BR0111536-7A priority patent/BR0111536A/en
Priority to CA002411065A priority patent/CA2411065A1/en
Priority to OA1200200370A priority patent/OA12284A/en
Priority to KR1020027016721A priority patent/KR20030007918A/en
Priority to APAP/P/2002/002673A priority patent/AP2002002673A0/en
Priority to PCT/GB2001/002567 priority patent/WO2001094344A1/en
Priority to EP01938400A priority patent/EP1296980A1/en
Priority to CN01813190A priority patent/CN1443186A/en
Priority to PL36059201A priority patent/PL360592A1/en
Priority to MXPA02012100A priority patent/MXPA02012100A/en
Priority to SK1714-2002A priority patent/SK17142002A3/en
Priority to CZ20023966A priority patent/CZ20023966A3/en
Priority to MA26933A priority patent/MA25753A1/en
Priority to BG107357A priority patent/BG107357A/en
Priority to NO20025883A priority patent/NO20025883L/en
Priority to ZA200209954A priority patent/ZA200209954B/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
GBGB0014006.1A 2000-06-08 2000-06-08 Novel pharmaceutical Ceased GB0014006D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
CZ20023966A CZ20023966A3 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treating diabetes mellitus
OA1200200370A OA12284A (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus.
APAP/P/2002/002673A AP2002002673A0 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for the treatment of diabetes mellitus.
DZ013382A DZ3382A1 (en) 2000-06-08 2001-06-08 THIAZOLIDINEDIONE SALT FOR THE TREATMENT OF SUGAR DIABETES
IL15327901A IL153279A0 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus
HU0301137A HUP0301137A3 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same
EA200300005A EA200300005A1 (en) 2000-06-08 2001-06-08 SALT THIAZOLIDINDION FOR THE TREATMENT OF DIABETES MELLITUS
JP2002501893A JP2003535862A (en) 2000-06-08 2001-06-08 Thiazolidinedione salts for the treatment of diabetes
BR0111536-7A BR0111536A (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for diabetes mellitus treatment
CA002411065A CA2411065A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus
US10/297,651 US20030162815A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus
KR1020027016721A KR20030007918A (en) 2000-06-08 2001-06-08 Thiazolidinedione Salt for Treatment of Diabetes Mellitus
AU2001264078A AU2001264078A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus
EP01938400A EP1296980A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus
CN01813190A CN1443186A (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus
PL36059201A PL360592A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus
MXPA02012100A MXPA02012100A (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus.
SK1714-2002A SK17142002A3 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus
MA26933A MA25753A1 (en) 2000-06-08 2002-12-04 THIAZOL IDINEDIONE SALT FOR THE TREATMENT OF DIABETES MELLIUS
BG107357A BG107357A (en) 2000-06-08 2002-12-05 Thiazolidinedione salt fore treatment of diabetes mellitus
NO20025883A NO20025883L (en) 2000-06-08 2002-12-06 Thiazolidinone salt for the treatment of diabetes mellitus
ZA200209954A ZA200209954B (en) 2000-06-08 2002-12-09 Thiazolidinedione salt for treatment of diabetes mellitus.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
GB0014006D0 true GB0014006D0 (en) 2000-08-02

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0014006.1A Ceased GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical

Country Status (23)

Country Link
EP (1) EP1296980A1 (en)
JP (1) JP2003535862A (en)
KR (1) KR20030007918A (en)
CN (1) CN1443186A (en)
AP (1) AP2002002673A0 (en)
AU (1) AU2001264078A1 (en)
BG (1) BG107357A (en)
BR (1) BR0111536A (en)
CA (1) CA2411065A1 (en)
CZ (1) CZ20023966A3 (en)
DZ (1) DZ3382A1 (en)
EA (1) EA200300005A1 (en)
GB (1) GB0014006D0 (en)
HU (1) HUP0301137A3 (en)
IL (1) IL153279A0 (en)
MA (1) MA25753A1 (en)
MX (1) MXPA02012100A (en)
NO (1) NO20025883L (en)
OA (1) OA12284A (en)
PL (1) PL360592A1 (en)
SK (1) SK17142002A3 (en)
WO (1) WO2001094344A1 (en)
ZA (1) ZA200209954B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone
US20080176905A1 (en) * 2007-01-22 2008-07-24 Santiago Ini Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (en) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Method of preparing a derivative of benzimidazole
US20100056583A1 (en) * 2008-08-21 2010-03-04 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
OA12284A (en) 2003-11-10
KR20030007918A (en) 2003-01-23
PL360592A1 (en) 2004-09-20
JP2003535862A (en) 2003-12-02
EA200300005A1 (en) 2003-04-24
CN1443186A (en) 2003-09-17
BG107357A (en) 2003-08-29
MXPA02012100A (en) 2003-04-25
HUP0301137A2 (en) 2003-08-28
EP1296980A1 (en) 2003-04-02
MA25753A1 (en) 2003-04-01
NO20025883D0 (en) 2002-12-06
IL153279A0 (en) 2003-07-06
AP2002002673A0 (en) 2002-12-31
CA2411065A1 (en) 2001-12-13
AU2001264078A1 (en) 2001-12-17
WO2001094344A1 (en) 2001-12-13
BR0111536A (en) 2003-07-01
NO20025883L (en) 2003-02-03
HUP0301137A3 (en) 2005-04-28
DZ3382A1 (en) 2001-12-13
SK17142002A3 (en) 2003-10-07
CZ20023966A3 (en) 2003-04-16
ZA200209954B (en) 2003-10-10

Similar Documents

Publication Publication Date Title
GB0006133D0 (en) Novel pharmaceutical
GB0025473D0 (en) Pharmaceutical combinations
GB0020691D0 (en) Pharmaceutical combination
GB0031084D0 (en) Pharmaceutical compounds
GB0012291D0 (en) Pharmaceutical combination
GB0021865D0 (en) Novel pharmaceutical
GB0019228D0 (en) Novel pharmaceutical
GB0019272D0 (en) Pharmaceutical compounds
GB0014006D0 (en) Novel pharmaceutical
GB0024318D0 (en) Pharmaceutical compounds
GB0019224D0 (en) Novel pharmaceutical
GB0019226D0 (en) Novel pharmaceutical
GB0023971D0 (en) Novel pharmaceutical
GB0014005D0 (en) Novel pharmaceutical
GB0005382D0 (en) Pharmaceutical composition
GB0021487D0 (en) Pharmaceutical
GB0005366D0 (en) Pharmaceutical compounds
HRP20030067A2 (en) Novel pharmaceutical
GB0023970D0 (en) Novel pharmaceutical
GB0021785D0 (en) Novel Pharmaceutical
GB0012293D0 (en) Pharmaceutical combination
EG24200A (en) Novel pharmaceutical
GB0031524D0 (en) Novel pharmaceutical
GB0031521D0 (en) Novel pharmaceutical
GB0031528D0 (en) Novel pharmaceutical

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)